A recent FiercePharma article discussed the shortage of anesthetics in U.S. hospitals due to increased demand from coronavirus patients. The FDA posted shortages last Friday, specifically calling out anesthetics propofol and midazolam. API sourcing difficulties could delay companies like Dr. Reddy’s Laboratories and Hikma Pharmaceuticals from resupplying propofol until October. Certain doses of midazolam are still available, but others may be delayed until early 2021.
Quick Hits: Coronavirus Causes Two Key Shortages
Increased demand due to the pandemic has caused shortages of key hospital painkillers.
Apr 17, 2020
Recommended
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
